Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
ACT Biotech Inc logo — company profile

ACT Biotech Inc

Founded 2008 6 employees Debt Financing Total: $25.98M Biotechnology, Health Care

General Information

Company Name ACT Biotech Inc
Founded Year 2008
Founders / Decision Makers
Team member
Employees 6
Industries Biotechnology, Health Care
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with ACT Biotech Inc. To contact ACT Biotech Inc, visit actbiotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ACT Biotech Inc compare?

A PDF of ACT Biotech Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ACT Biotech Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ACT Biotech Inc

ACT Biotech is a biotech startup established in 2008 that aims to revolutionize cancer treatment by addressing areas with significant patient need. With a highly experienced leadership team and a portfolio of pre-clinical drug candidates, the company is strategically positioned to bring groundbreaking therapies to market. Their aggressive development strategy is geared towards expediting the delivery of these therapeutic solutions, showcasing their determination to make a meaningful impact in the field of cancer care. Moreover, the recent $1.00M Debt Financing investment in 11 June 2010 underscores the confidence in ACT's potential. With a strong foundation and validated drug compounds, ACT Biotech offers compelling opportunities for corporate partnerships, positioning it as an attractive prospect for potential investors seeking to contribute to the advancement of cancer treatment.

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $1.00M -
11 Jun 2010
Venture Round $500.00K -
14 Oct 2009
Series A $11.67M -
01 Mar 2009
Series A $6.24M -
08 Sep 2008
Series A $6.57M 1
NGN Capital
NGN Capital
06 May 2008

ACT Biotech Inc Alternatives & Competitors

View All Alternatives
ACT Biotech Inc vs
Advenchen Laboratories, LLC
Advenchen Laboratories, LLC

Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter future in...

Venture round
6 employees
Biotechnology, Health Care
ACT Biotech Inc vs
Thelial Technologies
Thelial Technologies

Discovering and developing targeted carcinoma therapies through innovative drug discovery and reposi...

Grant
Biotechnology, Health Care
ACT Biotech Inc vs
BioInvent International AB
BioInvent International AB Sweden

BioInvent is translating cancer antibody biology into innovative immuno-oncology therapies.

IPO
139 employees
Biotechnology, Health Care
View all alternatives

FAQ About ACT Biotech Inc

ACT Biotech is strategically poised to introduce groundbreaking therapies for cancer treatment, particularly in areas with significant patient need. The company boasts a seasoned leadership team with global experience, unparalleled clinical development and commercialization expertise, and a remarkab...
ACT Biotech Inc was founded in 2008.
ACT Biotech Inc operates in Biotechnology and Health Care.
ACT Biotech Inc has approximately 6 employees.
ACT Biotech Inc has completed 5 funding rounds, raising a total of $25.98M. The latest funding stage is Debt Financing.
Top alternatives and competitors to ACT Biotech Inc include Advenchen Laboratories, LLC, Thelial Technologies, BioInvent International AB, Boston Biomedical, Inc., Sierra Oncology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ACT Biotech Inc and Advenchen Laboratories, LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ACT Biotech Inc, https://bouncewatch.com/company/act-biotech, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes